The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling

Journal of Clinical Investigation

Volumn 117, Issue 10, 2007, Pages 3075-3086

  Nakamura, Yukio ^a,d,f   Weidinger, Gilbert ^b   Liang, Jennifer O ^c   Aquilina Beck, Allisan ^c   Tamai, Keiko ^d   Moon, Randall T ^b   Warman, Matthew L ^a,d,e,f  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Children's Hosptial Boston   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 INDUCIBLE SIGNALING PATHWAY PROTEIN 3;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SPONDYLOEPIPHYSEAL DYSPLASIA; ZEBRA FISH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL ASSAY; BONE MORPHOGENETIC PROTEINS; CLONING, MOLECULAR; DISEASE PROGRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; OSTEOCHONDRODYSPLASIAS; SIGNAL TRANSDUCTION; WNT PROTEINS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 34948831652     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI32001     Document Type: Article

References (68)

1. Hurvitz, J.R., et al. 1999. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23:94-98.
2. Sewairi, W., and Warman, M.L. 2003. Wisp3 and progressive pseudorheumatoid dysplasia. In Molecular basis of inborn errors of development. C.J. Epstein, A. Wynshaw-Boris, and R.P. Erickson, editors. Oxford University Press. Oxford, United Kingdom. 282-284.
3. Spranger, J., Albert, C., Schilling, F., and Bartsocas, C. 1983. Progressive pseudorheumatoid arthropathy of childhood (PPAC): a hereditary disorder simulating juvenile rheumatoid arthritis. Am. J. Med. Genet. 14:399-401.
4. Wynne-Davies, R., Hall, C., and Ansell, B.M. 1982. Spondylo-epiphysial dysplasia tarda with progressive arthropathy. A "new" disorder of autosomal recessive inheritance. J. Bone Joint Surg. Br. 64:442-445.
5. el-Shanti, H.E., Omari, H.Z., and Qubain, H.I. 1997. Progressive pseudorheumatoid dysplasia: report of a family and review. J. Med. Genet. 34:559-563.
6. Ehl, S., et al. 2004. Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy. Rheumatol. Int. 24:53-56.
7. Delague, V., et al. 2005. Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect. Am. J. Med. Genet. A. 138:118-126.
8. Rachfal, A.W., and Brigstock, D.R. 2005. Structural and functional properties of CCN proteins. Vitam. Horm. 70:69-103.
9. Leask, A., and Abraham, D.J. 2006. All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J. Cell Sci. 119:4803-4810.
10. Pennica, D., et al. 1998. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U. S. A. 95:14717-14722.
11. Brigstock, D.R. 2003. The CCN family: a new stimulus package. J. Endocrinol. 178:169-175.
12. Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet. 363:62-64.
13. Brunkow, M.E., et al. 2001. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68:577-589.
14. Itasaki, N., et al. 2003. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development. 130:4295-4305.
15. Avsian-Kretchmer, O., and Hsueh, A.J. 2004. Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol. Endocrinol. 18:1-12.
16. Piccolo, S., et al. 1999. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature. 397:707-710.
17. Ivkovic, S., et al. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 130:2779-2791.
18. Mo, F.E., et al. 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 22:8709-8720.
19. Sen, M., Cheng, Y.H., Goldring, M.B., Lotz, M.K., and Carson, D.A. 2004. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum. 50:488-497.
20. Kleer, C.G., Zhang, Y., Pan, Q., and Merajver, S.D. 2004. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia. 6:179-185.
21. Kleer, C.G., et al. 2004. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res. 6:R110-R115.
22. Kleer, C.G., et al. 2002. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21:3172-3180.
23. Miller, D.S., and Sen, M. 2007. Potential role of WISP3 (CCN6) in regulating the accumulation of reactive oxygen species. Biochem. Biophys. Res. Commun. 355:156-161.
24. Zhang, Y., Pan, Q., Zhong, H., Merajver, S.D., and Kleer, C.G. 2005. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res. 7:R1080-R1089.
25. Zhou, H.D., et al. 2007. Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. J. Mol. Med. In press.
26. Davis, L., Chen, Y., and Sen, M. 2006. WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem. Biophys. Res. Commun. 342:259-265.
27. Kutz, W.E., Gong, Y., and Warman, M.L. 2005. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol. Cell. Biol. 25:414-421.
28. Schier, A.F., and Talbot, W.S. 2005. Molecular genetics of axis formation in zebrafish. Annu. Rev. Genet. 39:561-613.
29. Hild, M., et al. 1999. The smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning of the zebrafish embryo. Development. 126:2149-2159.
30. Kishimoto, Y., Lee, K.H., Zon, L., Hammerschmidt, M., and Schulte-Merker, S. 1997. The molecular nature of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning. Development. 124:4457-4466.
31. Semenov, M.V., and He, X. 2006. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J. Biol. Chem. 281:38276-38284.
32. Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R., and Smith, J.C. 2004. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development. 131:2137-2147.
33. Latinkic, B.V., et al. 2003. Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development. 130:2429- 2441.
34. Lekven, A.C., Thorpe, C.J., Waxman, J.S., and Moon, R.T. 2001. Zebrafish wnt8 encodes two wnt8 proteins on a bicistronic transcript and is required for mesoderm and neurectoderm patterning. Dev. Cell. 1:103-114.
35. Hashimoto, H., et al. 2000. Zebrafish Dkk1 functions in forebrain specification and axial mesendoderm formation. Dev. Biol. 217:138-152.
36. Shimizu, T., Bae, Y.K., Muraoka, O., and Hibi, M. 2005. Interaction of Wnt and caudal-related genes in zebrafish posterior body formation. Dev. Biol. 279:125-141.
37. Thorpe, C.J., Weidinger, G., and Moon, R.T. 2005. Wnt/beta-catenin regulation of the Sp1-related transcription factor sp5l promotes tail development in zebrafish. Development. 132:1763-1772.
38. Katagiri, T., et al. 1990. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172:295-299.
39. Zimmerman, L.B., De Jesus-Escobar, J.M., and Harland, R.M. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:599-606.
40. Semenov, M.V., et al. 2001. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11:951-961.
41. Mao, B., and Niehrs, C. 2003. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene. 302:179-183.
42. Abreu, J.G., Ketpura, N.I., Reversade, B., and De Robertis, E.M. 2002. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 4:599-604.
43. Kimmel, C.B., Miller, C.T., and Moens, C.B. 2001. Specification and morphogenesis of the zebrafish larval head skeleton. Dev. Biol. 233:239-257.
44. Yoon, B.S., et al. 2005. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:5062-5067.
45. Rountree, R.B., et al. 2004. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol. 2:e355.
46. Kizawa, H., et al. 2005. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37:138-144.
47. Miyamoto, Y., et al. 2007. A functional polymorphism in the 5′UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39:529-533.
48. Spater, D., et al. 2006. Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis. Development. 133:3039-3049.
49. Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W., and Hartmann, C. 2005. Canonical Wnt/betacatenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell. 8:727-738.
50. Gong, Y., et al. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 107:513-523.
51. Clement-Lacroix, P., et al. 2005. Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc. Natl. Acad. Sci. U. S. A. 102:17406-17411.
52. Kato, M., et al. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J. Cell Biol. 157:303-314.
53. Loughlin, J., et al. 2004. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc. Natl. Acad. Sci. U. S. A. 101:9757-9762.
54. Lane, N.E., et al. 2006. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 54:1246-1254.
55. Dell'Accio, F., et al. 2006. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res. Ther. 8:R139.
56. Aszodi, A., Bateman, J.F., Gustafsson, E., Boot-Handford, R., and Fassler, R. 2000. Mammalian skeletogenesis and extracellular matrix: what can we learn from knockout mice? Cell Struct. Funct. 25:73-84.
57. Ramel, M.C., Buckles, G.R., Baker, K.D., and Lekven, A.C. 2005. WNT8 and BMP2B co-regulate non-axial mesoderm patterning during zebrafish gastrulation. Dev. Biol. 287:237-248.
58. Westerfield, M. 1994. The zebrafish book: a guide for the laboratory use of zebrafish. University of Oregon Press. Eugene, Oregon, USA. 385 pp.
59. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. 1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 203:253-310.
60. Thisse, C., Thisse, B., Schilling, T.F., and Postlethwait, J.H. 1993. Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development. 119:1203-1215.
61. Tamai, K., et al. 2000. LDL-receptor-related proteins in Wnt signal transduction. Nature. 407:530-535.
62. Holmen, S.L., Salic, A., Zylstra, C.R., Kirschner, M.W., and Williams, B.O. 2002. A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta -catenin-dependent signaling. J. Biol. Chem. 277:34727-34735.
63. Tamai, K., et al. 2004. A mechanism for Wnt coreceptor activation. Mol. Cell. 13:149-156.
64. Ai, M., et al. 2005. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25:4946-4955.
65. Blitzer, J.T., and Nusse, R. 2006. A critical role for endocytosis in Wnt signaling. BMC Cell Biol. 7:28.
66. Constam, D.B., and Robertson, E.J. 1999. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 144:139-149.
67. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
68. Nasevicius, A., and Ekker, S.C. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26:216-220.